No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Verici Dx said on Friday that it had raised about 190,000 through its WRAP retail offer, taking total gross proceeds from the offer and an associated placing to approximately 2.6m.
The AIM-traded developer of organ transplant diagnostics said it would issue 53,345,832 retail offer shares at 0.35p each.
The retail offer proceeds are in addition to the previously announced placing of 700 million shares at the same issue price.
In total, Verici Dx will issue 753,345,832 new shares through the placing and retail offer.
The retail offer was conducted separately from the placing and remained conditional on shareholders approving certain resolutions at a general meeting scheduled for 22 June, as well as the new shares being admitted to trading on AIM.
At 1216 BST, shares in Verici Dx were down 1.33% at 0.37p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.